USA – Restrictions on fetal tissue research would threaten progress on breakthrough treatments for devastating diseases — and yet not prevent a single abortion

By Lawrence S. B. Goldstein
Nov 8, 2025

Human fetal tissue (HFT) research has been indispensable for understanding and combating diseases that affect millions worldwide. Reports that the National Institutes of Health (NIH) may not renew grants supporting this work are deeply troubling, as such action would jeopardize progress against devastating conditions including cancer, multiple sclerosis, Parkinson’s disease, eye disorders, and neurological and rare diseases.

For decades, HFT has been funded by the U.S. government. It’s had broad bipartisan support under both Republican and Democratic administrations because this research has saved lives. Yet, there are early signs that the Trump administration may ban ethical and well-established uses of fetal tissue in important medical research based on politics rather than science.

Continued: https://www.livescience.com/health/restrictions-on-fetal-tissue-research-would-threaten-progress-on-breakthrough-treatments-for-devastating-diseases-and-yet-not-prevent-a-single-abortion


USA – The Abortion Pill Is Safe. Scientists Fear an FDA Investigation Will Ignore Science

Some scientists are concerned that the Trump administration will use “junk science” when reviewing mifepristone’s safety record

October 30, 2025
By Liz Szabo

Secretary of Health and Human Services Robert F. Kennedy, Jr., recently announced that the U.S. Food and Drug Administration will launch a review of the safety of the abortion pill, mifepristone. Health researchers say they’re concerned that the review will be politicized and based on flawed reports. More than 100 studies published over the past few decades have shown that the drug, which was approved by the FDA in 2000, is safe and effective at ending a pregnancy.

Given Kennedy’s history of misrepresenting scientific evidence about vaccines, autism and Tylenol, some scientists say they worry that the health secretary will base the FDA report on unreliable sources.

Continued: https://www.scientificamerican.com/article/fda-is-investigating-the-abortion-pill-mifepristone-despite-decades-of/


Celebrating mifepristone, a hero in modern abortion access, on its 25th anniversary in the U.S.

Though it faces new legal challenges, mifepristone may offer yet more

By Elisa Wells
Sept. 28, 2025

When the Food and Drug Administration approved mifepristone, the abortion pill, on Sept. 28, 2000, none of us working on expanding access to reproductive health care could have imagined the future we find ourselves in 25 years later. From the fall of Roe in 2022 and the subsequent banning or restriction of abortion in 19 states, to South Carolina’s recent efforts to include some forms of birth control in its total abortion ban, access to the basic medical care and medications that allow us to control our reproductive destinies is hanging by a thread. In the midst of this reproductive health care apocalypse, mifepristone is proving itself to be a hero in the fight for abortion access.

Continued: https://www.statnews.com/2025/09/28/mifepristone-abortion-pill-fda-approval-25th-anniversary/


USA – Abortion opponents are coming for mifepristone using what medical experts call “junk science”

Using flawed studies and scientific journal publications, abortion opponents are building a body of research meant to question the safety of the abortion pill mifepristone, a key target for the movement.

Shefali Luthra
May 30, 2025

Using flawed studies and scientific journal publications, abortion opponents are building a body of research meant to question the safety of the abortion pill mifepristone, a key target for the movement.

The effort comes as federal officials have expressed a willingness to revisit the drug’s approval — and potentially impose new restrictions on a medication used in the vast majority of abortions.

Continued: https://19thnews.org/2025/05/abortion-opponents-mifepristone-junk-science/


USA – How shoddy science is fueling a charge to restrict abortion pill access

The FDA has been tasked with re-evaluating the safety of mifepristone after a flawed report claimed it has a high rate of serious complications.

May 19, 2025
By Aria Bendix

Health and Human Services Secretary Robert F. Kennedy Jr. has tasked the Food and Drug Administration with conducting a safety review of mifepristone, a pill used in most U.S. abortions. Kennedy said this week that the review was warranted due to an “alarming” new report on serious adverse events released last month.

“Clearly it indicates that, at very least, the label should be changed,” he told Sen. Josh Hawley, R-Mo., at a Senate budget hearing on Wednesday. “I’ve asked Marty Makary, who’s the director of FDA, to do a complete review and to report back.”

Continued: https://www.nbcnews.com/health/womens-health/shoddy-science-fueling-charge-restrict-abortion-pill-access-rcna207034


USA – Abortion providers challenge FDA’s remaining mifepristone restrictions in federal court

“It’s really important that we protect … safe access to medication abortion no matter where people live — Virginia is playing a key role in the South right now,” Whole Woman’s Health Alliance founder and president Amy Hagstrom Miller said Monday.

By: Sofia Resnick and Charlotte Rene Woods
May 19, 2025

CHARLOTTESVILLE, Va. — Abortion pills — and questions over their inherent safety — were back in federal court Monday. Unlike a lawsuit rejected by the U.S. Supreme Court last year, plaintiffs this time are not anti-abortion activists arguing medication abortion should be banned, but abortion providers arguing the remaining restrictions should be lifted to match the drug’s 25-year record of safety and efficacy.

The suit seeks to make abortion pills more accessible by removing several existing restrictions on the U.S. Food and Drug Administration’s mifepristone-misoprostol regimen first approved in 2000. The drug was approved under the FDA’s drug safety program called Risk Evaluation and Mitigation Strategy (REMS), provisions of which have been steadily eliminated over time but not fully.

Continued: https://virginiamercury.com/2025/05/19/abortion-providers-challenge-fdas-remaining-mifepristone-restrictions-in-federal-court/


USA – RFK Jr. Is Coming for Abortion Pills

And he’s relying on bogus science to make his case.

Julianne McShane, Mother Jones
May 15, 2025

Earlier this month, the Trump administration scored seemingly positive headlines when it asked a federal court to dismiss a case brought by three Republican states seeking to restrict telehealth access to mifepristone, the first of two drugs used in a medication abortion.

Several news outlets claimed in headlines that the administration would “defend” access to the pills, despite the fact that Project 2025 and several of Trump’s top appointees have made it clear that they believe access to mifepristone—which, along with the second drug, misoprostol, now account for more than 60 percent of all abortions that occur nationwide—should be drastically rolled back, as I have previously reported. In reality, the administration merely argued the states do not have standing to sue and did not weigh in on the underlying issue of access to the pills.

Continued: https://www.motherjones.com/politics/2025/05/rfk-jr-is-coming-for-abortion-pills/


RFK Jr orders mifepristone review as anti-abortion groups push for ban

Health secretary cites ‘new data’ that emerged from flawed study conservatives are using to pressure US government

Susan Rinkunas
Wed 14 May 2025

The US health secretary, Robert F Kennedy Jr, said on Wednesday that he had directed the FDA to review the regulations around the abortion pill mifepristone.

The review, he said, was necessary due to “new data” – data that emerged from a flawed analysis that top US anti-abortion groups are now using to pressure the Trump administration to reimpose restrictions on the abortion pill, if not pull it from the market entirely.

“It’s alarming,” Kennedy told the Missouri senator Josh Hawley, a Republican, during a congressional hearing. “Clearly, it indicates that, at very least, the label should be changed.”

Continued: https://www.theguardian.com/us-news/2025/may/14/rfk-jr-fda-abortion-pill-mifepristone


USA – What Would It Mean to Defend All Abortions?

Democrats love to avoid it, and Republicans love to lie about it. But later-abortion care has never been more important.

Amy Littlefield
May 13, 2025

Ayana, 28 years old and 28 weeks pregnant, eases herself onto the procedure table at Partners in Abortion Care in College Park, Maryland. She is a Black woman with the tiny bearing and erect posture of a bird. Above her head, a flock of pink and blue butterflies decorates the ceiling. In a few minutes, a doctor will perform an injection to the fetal heart to end her pregnancy.

Ayana had spent months in turmoil over this abortion. As she chased after her two older kids while lugging her 1-year-old on family outings to the arcade and the movies, she tried to imagine hauling two car seats instead of one. While she changed her baby’s diapers, she thought about what a newborn would subtract from him. The family was already stretched thin.

Continued: https://www.thenation.com/article/society/defending-all-abortions/